跳至主要内容
临床试验/NCT07006311
NCT07006311终止不适用

Robotic-assisted Bronchoscopy Under Moderate Sedation With Propofol: A Single-center Pilot Study.

University of Zurich2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2025年8月14日最近更新:
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
10
试验地点
2
主要终点
histopathological classification of the pulmonary lesion

研究概览

简要总结

In this study, the investigators want to find out whether robot-assisted bronchoscopy also works with moderate sedation (Propofol), as is already used in standard bronchoscopies. The study is being conducted as a pilot study. This means that it is an initial test run for a scientific investigation. The investigators are testing on a small scale whether the intervention works as predicted before a larger study is conducted.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • informed consent signed by the subject
  • aged at least 18 years
  • scheduled for bronchoscopy with moderate sedation and tracheal intubation in order to obtain at least 1 specimens of the lung via transbronchial biopsy
  • necessary periinterventional laboratory examinations needed for the bronchoscopy
  • judgement of the subject

排除标准

  • endobronchial lesion causing lobar atelectasis
  • inability or contraindications to undergo bronchoscopy (e.g. severe cardiopulmonary diseases, coagulation disorders, intolerance to anesthesia or endoscopic operation, psychiatric disorders or severe neurosis)
  • pregnant or lactating women

研究组 & 干预措施

Robotic-assisted bronchoscopy with Propofol

Experimental

干预措施: Robotic-assisted bronchoscopy under propofol (Device)

结局指标

主要结局

histopathological classification of the pulmonary lesion

时间窗: From enrollment to the end of treatment at 8 days.

Confirmation of tool-in-lesion

时间窗: during the intervention

Composite outcome defined as meeting at least one of the following criteria: 1) Radiological confirmation of the biopsy tool located within the target lung lesion using cone-beam CT. 2) Positive signal on radial endobronchial ultrasound (rEBUS) indicating the lesion was reached. 3) Pathological confirmation of specific malignant or benign tissue in the biopsy sample.

Acquisition of at least one histological sample

时间窗: during the intervention

次要结局

  • Procedure duration(during the intervention)
  • Diagnostic yield of biopsies(From enrollment to the end of treatment at 8 days.)
  • diagnostic accuracy for malignancy(From enrollment to the end of treatment of 3 months)
  • cost analysis(From enrollment to the end of treatment at 8 days.)
  • Safety profile(From enrollment to the end of treatment at 8 days.)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验